Shareholders Equity: The sum of preferred and common equity items.
Moderna, Inc. (MRNA) had Shareholders Equity of $6.76B for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$145.00M |
|
$-782.00M |
|
$93.00M |
|
$52.00M |
|
$960.00M |
|
$-815.00M |
|
$48.00M |
|
$-767.00M |
|
$-767.00M |
|
$-782.00M |
|
$-782.00M |
|
$-782.00M |
|
$-782.00M |
|
$-815.00M |
|
$-762.00M |
|
398.00M |
|
398.00M |
|
$-1.97 |
|
$-1.97 |
|
| Balance Sheet Financials | |
$5.82B |
|
$2.06B |
|
$5.15B |
|
$10.96B |
|
$2.53B |
|
$597.00M |
|
$1.67B |
|
$4.20B |
|
$6.76B |
|
$6.76B |
|
|
Shareholders Equity |
$6.76B |
399.00M |
|
| Cash Flow Statement Financials | |
$-1.16B |
|
$253.00M |
|
$31.00M |
|
$2.60B |
|
$1.72B |
|
$-873.00M |
|
$224.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.29 |
|
-- |
|
-- |
|
0.08 |
|
0.09 |
|
35.86% |
|
-562.07% |
|
-562.07% |
|
-- |
|
-528.97% |
|
-539.31% |
|
$-1.25B |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.33 |
|
8.53 |
|
10.55 |
|
-11.57% |
|
-11.57% |
|
-7.13% |
|
-10.63% |
|
$16.94 |
|
$-3.15 |
|
$-2.90 |
|